US10667730B2ExpiredUtilityA1
Analyte sensing biointerface
Est. expiryApr 15, 2025(expired)· nominal 20-yr term from priority
A61B 5/14532A61B 5/14865A61B 5/0031A61B 5/1486C12Q 1/001B33Y 80/00C12Q 1/006
70
PatentIndex Score
0
Cited by
668
References
9
Claims
Abstract
Disclosed herein is an analyte sensing biointerface that comprises a sensing electrode incorporated within a non-conductive matrix comprising a plurality of passageways extending through the matrix to the sensing electrode. Also disclosed herein are methods of manufacturing a sensing biointerface and methods of detecting an analyte within tissue of a host using an analyte sensing biointerface.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A transcutaneous continuous glucose sensor system, comprising:
a substantially planar sensor, the sensor comprising:
a first non-conductive layer;
a first conductive layer associated with a first electrode, wherein the first conductive layer is disposed over at least a portion of the first non-conductive layer, wherein the first electrode is a counter electrode;
a second non-conductive layer disposed over at least a portion of the first conductive layer;
a second conductive layer associated with a second electrode, wherein the second conductive layer is disposed over at least a portion of the second non-conductive layer, wherein the second electrode is a working electrode;
a third non-conductive layer disposed over at least a portion of the second conductive layer;
a third conductive layer associated with a third electrode, wherein the third conductive layer is disposed over at least a portion of the third non-conductive layer, wherein the third electrode is a reference electrode; and
a membrane disposed over at least a portion of the working electrode.
2. The transcutaneous continuous glucose sensor system of claim 1 , wherein the membrane comprises an enzyme.
3. The transcutaneous continuous glucose sensor system of claim 2 , wherein the membrane further comprises a resistance domain disposed over the enzyme.
4. The transcutaneous continuous glucose sensor system of claim 1 , wherein the membrane further comprises a bioactive agent.
5. The transcutaneous continuous glucose sensor system of claim 1 , wherein the membrane is substantially planar.
6. The transcutaneous continuous glucose sensor system of claim 1 , wherein at least a portion of the first non-conductive layer is in contact with at least a portion of the first conductive layer.
7. The transcutaneous continuous glucose sensor system of claim 1 , further comprising sensor electronics configured to electrically couple to the working electrode.
8. The transcutaneous continuous glucose sensor system of claim 1 , wherein at least a portion of the first non-conductive layer is physically separate from the first conductive layer.
9. The transcutaneous continuous glucose sensor system of claim 1 , further comprising sensor electronics comprising at least one contact for establishing electrical communication with the working electrode.Join the waitlist — get patent alerts
Track US10667730B2 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.